Magnetic Insight, Inc
Magnetic Particle Imaging - Advancing Molecular Imaging
Magnetic Particle Imaging - Advancing Molecular Imaging
Magnetic Insight is a biotechnology company based in the United States, specializing in magnetic particle imaging (MPI) technology. Founded in 2014, the company aims to revolutionize molecular imaging in clinical and translational research.
Unlike other existing technologies, MPI is a functional imaging modality enabling real-time monitoring of biological events, offering the ability to target biomarkers and support real-time blood flow and vascular architecture with direct quantitation. This groundbreaking technology utilizes the magnetic properties of iron oxide nanoparticles, providing specific, direct, and unobstructed visualization and quantitation with exquisite sensitivity and resolution.
Most recently, Magnetic Insight secured a $3.00M grant investment on 11 April 2024, with the backing of the University of California Berkeley. This strategic partnership and investment signal a significant validation of the company's pioneering approach to molecular imaging.
As the biotechnology and healthcare industries continue to seek innovative solutions, Magnetic Insight's advancements in MPI position the company as a key player in the evolution of imaging technologies, with the potential to drive impactful developments in clinical and translational research.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $3.00M | 1 | University of California Berkeley | 11 Apr 2024 |
| Series B | $17.00M | 7 |
|
23 Jun 2022 |
| Series B | Unknown | 1 |
|
17 Oct 2021 |
| Grant | $1.60M | 1 | National Institutes of Health | 01 Sep 2020 |
| Grant | $1.80M | 1 | National Institutes of Health | 01 Jun 2019 |
No recent news or press coverage available for Magnetic Insight, Inc.
We care about your data, and we'd love to use cookies make your experience better.
